Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis

Molecular Nutrition and Food Research

Volumn 55, Issue 5, 2011, Pages 703-713

  Hoffmann, Micha ^a   Messlik, Anja ^a   Kim, Sandra C ^b   Sartor, Ryan B ^b   Haller, Dirk ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Colitis; Enterococcus faecalis; IL 10 deficient mice; Inflammatory bowel disease; Probiotic

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MOLECULAR CHAPERONE GRP78; PROBIOTIC AGENT; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; CELL CULTURE; COLITIS; DISEASE MODEL; ENTEROCOCCUS FAECALIS; GERMFREE ANIMAL; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL10; COLITIS; DISEASE MODELS, ANIMAL; ENTEROCOCCUS FAECALIS; GERM-FREE LIFE; HEAT-SHOCK PROTEINS; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C3H; NF-KAPPA B; PROBIOTICS; TOLL-LIKE RECEPTOR 2;

ENTEROCOCCUS FAECALIS; MURINAE; MUS;

EID: 79955618023     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000361     Document Type: Article

References (56)

1. Loftus, E. V., Jr., Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126, 1504-1517.
2. Ahmad, T., Tamboli, C. P., Jewell, D., Colombel, J. F., Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004, 126, 1533-1549.
3. Bouma, G., Strober, W., The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003, 3, 521-533.
4. Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A. et al., Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 1998, 66, 5224-5231.
5. Dianda, L., Hanby, A. M., Wright, N. A., Sebesteny, A. et al., T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 1997, 150, 91-97.
6. Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A. et al., The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 1994, 180, 2359-2364.
7. Haller, D., Intestinal epithelial cell signalling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neurogastroenterol. Motil. 2006, 18, 184-199.
8. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S. et al., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411, 599-603.
9. Franchimont, D., Vermeire, S., El Housni, H., Pierik, M. et al., Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53, 987-992.
10. Pierik, M., Joossens, S., Van Steen, K., Van Schuerbeek, N. et al., Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 2006, 12, 1-8.
11. Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H. et al., Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008, 40, 955-962.
12. Wapenaar, M. C., Monsuur, A. J., van Bodegraven, A. A., Weersma, R. K. et al., Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008, 57, 463-467.
13. Cho, J. H., The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 2008, 8, 458-466.
14. Kropec, A., Hufnagel, M., Zimmermann, K., Huebner, J., In vitro assessment of the host response against Enterococcus faecalis used in probiotic preparations. Infection 2005, 33, 377-379.
15. Centeno, J. A., Menendez, S., Hermida, M., Rodriguez-Otero, J. L., Effects of the addition of Enterococcus faecalis in Cebreiro cheese manufacture. Int. J. Food Microbiol. 1999, 48, 97-111.
16. Hugas, M., Garriga, M., Aymerich, M. T., Functionality of enterococci in meat products. Int. J. Food Microbiol. 2003, 88, 223-233.
17. Nallapareddy, S. R., Singh, K. V., Sillanpaa, J., Garsin, D. A. et al., Endocarditis and biofilm-associated pili of Enterococcus faecalis. J. Clin. Invest. 2006, 116, 2799-2807.
18. Graninger, W., Ragette, R., Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin. Infect. Dis. 1992, 15, 49-57.
19. Stuart, C. H., Schwartz, S. A., Beeson, T. J., Owatz, C. B., Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J Endod. 2006, 32, 93-98.
20. Guzman, C. A., Pruzzo, C., LiPira, G., Calegari, L., Role of adherence in pathogenesis of Enterococcus faecalis urinary tract infection and endocarditis. Infect. Immun. 1989, 57, 1834-1838.
21. Balish, E., Warner, T., Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 2002, 160, 2253-2257.
22. Shkoda, A., Ruiz, P. A., Daniel, H., Kim, S. C. et al., Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology 2007, 132, 190-207.
23. Hoffmann, M., Kim, S. C., Sartor, R. B., Haller, D., Enterococcus faecalis strains differentially regulate Alix/AIP1 protein expression and ERK 1/2 activation in intestinal epithelial cells in the context of chronic experimental colitis. J. Proteome Res. 2009, 8, 1183-1192.
24. Atreya, R., Neurath, M. F., Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin. Rev. Allergy Immunol. 2005, 28, 187-196.
25. Larsson, B. M., Larsson, K., Malmberg, P., Palmberg, L., Gram positive bacteria induce IL-6 and IL-8 production in human alveolar macrophages and epithelial cells. Inflammation 1999, 23, 217-230.
26. Noguchi, A., Watanabe, K., Narumi, S., Yamagami, H. et al., The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity. J. Gastroenterol. 2007, 42, 947-956.
27. -/- mice. J. Immunol. 2003, 171, 1401-1406.
28. Berg, D. J., Davidson, N., Kuhn, R., Muller, W. et al., Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 1996, 98, 1010-1020.
29. Vidal, K., Grosjean, I., Revillard, J. P., Gespach, C., Kaiserlian, D., Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. J. Immunol. Methods 1993, 166, 63-73.
30. Sultzer, B. M., Castagna, R., Bandekar, J., Wong, P., Lipopolysaccharide nonresponder cells: the C3H/HeJ defect. Immunobiology 1993, 187, 257-271.
31. Messlik, A., Schmechel, S., Kisling, S., Bereswill, S. et al., Loss of Toll-like receptor 2 and 4 leads to differential induction of endoplasmic reticulum stress and proapoptotic responses in the intestinal epithelium under conditions of chronic inflammation. J. Proteome Res. 2009, 8, 4406-4417.
32. Brown, M. D., Sacks, D. B., Protein scaffolds in MAP kinase signalling. Cell Signal. 2009, 21, 462-469.
33. Leendertse, M., Willems, R. J., Giebelen, I. A., van den Pangaart, P. S. et al., TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis. J. Immunol. 2008, 180, 4865-4874.
34. Baik, J. E., Ryu, Y. H., Han, J. Y., Im, J. et al., Lipoteichoic acid partially contributes to the inflammatory responses to Enterococcus faecalis. J. Endod. 2008, 34, 975-982.
35. van Baarlen, P., Troost, F. J., van Hemert, S., van der Meer, C. et al., Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. USA 2009, 106, 2371-2376.
36. Elson, C. O., Cong, Y., Lorenz, R., Weaver, C. T., New developments in experimental models of inflammatory bowel disease. Curr. Opin. Gastroenterol. 2004, 20, 360-367.
37. Hormannsperger, G., Clavel, T., Hoffmann, M., Reiff, C. et al., Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS ONE 2009, 4, e4365.
38. Hormannsperger, G., Haller, D., Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease. Int. J. Med. Microbiol. 2010, 300, 63-73.
39. Sans, M., Probiotics for inflammatory bowel disease: a critical appraisal. Dig. Dis. 2009, 27, 111-114.
40. Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M. et al., Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004, 53, 1617-1623.
41. Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L. et al., VSL{music sharp sign}3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 2005, 100, 1539-1546.
42. Gionchetti, P., Rizzello, F., Morselli, C., Poggioli, G. et al., High-dose probiotics for the treatment of active pouchitis. Dis. Colon Rectum 2007, 50, 2075-2082; discussion 2082-2084.
43. Prantera, C., Scribano, M. L., Falasco, G., Andreoli, A., Luzi, C., Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002, 51, 405-409.
44. Marteau, P., Lemann, M., Seksik, P., Laharie, D. et al., Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006, 55, 842-847.
45. Kamada, N., Inoue, N., Hisamatsu, T., Okamoto, S. et al., Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis. Inflamm. Bowel Dis. 2005, 11, 455-463.
46. Madsen, K., Cornish, A., Soper, P., McKaigney, C. et al., Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121, 580-591.
47. Kim, S. C., Tonkonogy, S. L., Karrasch, T., Jobin, C., Sartor, R. B., Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm. Bowel Dis. 2007, 13, 1457-1466.
48. Kim, S. C., Tonkonogy, S. L., Albright, C. A., Tsang, J. et al., Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005, 128, 891-906.
49. Shkoda, A., PhD Thesis, Fachgebiet für Experimentelle Ernährungsmedizin, Technische Universität München, Freising-Weihenstephan 2006.
50. Spicer, A. P., Kaback, L. A., Smith, T. J., Seldin, M. F., Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes. J. Biol. Chem. 1998, 273, 25117-25124.
51. Baldassarri, L., Bertuccini, L., Creti, R., Filippini, P. et al., Glycosaminoglycans mediate invasion and survival of Enterococcus faecalis into macrophages. J. Infect. Dis. 2005, 191, 1253-1262.
52. Sava, I. G., Zhang, F., Toma, I., Theilacker, C. et al., Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. J. Biol. Chem. 2009, 284, 18194-18201.
53. Kaser, A., Lee, A. H., Franke, A., Glickman, J. N. et al., XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008, 134, 743-756.
54. Martinon, F., Chen, X., Lee, A. H., Glimcher, L. H., TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat. Immunol. 2010, 11, 411-418.
55. Nagahara, N., Sawada, N., The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase. Curr. Med. Chem. 2006, 13, 1219-1230.
56. Ramasamy, S., Singh, S., Taniere, P., Langman, M. J., Eggo, M. C., Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291, G288-G296.